Skip to main content
 

Evaluation of breast cancer screening strategies must be based on comparison of harms and benefits.

Abstract

Comment on
United States Preventive Services Task Force screening mammography recommendations: science ignored. [AJR Am J Roentgenol. 2011]

To read more, see the following article on the PubMed website: PMID: 21940562